Skip to main content

Table 1 Baseline characteristics

From: Prognostic significance of positive family history in outcomes after coronary artery bypass grafting: Do we need to update our assumptions?

Variable

Total (n = 13,156)

With FHpCVD (n = 2684)

Without FHpCVD (n = 10,472)

P-value

Age (years)

60.83 ± 9.57

57.25 ± 9.33

61.75 ± 9.42

< 0.001

Male gender

9798 (74.5%)

1878 (70.0%)

7920 (75.6%)

< 0.001

BMI (kg/m2)

    

 < 18.5

89 (0.7%)

17 (0.6%)

72 (0.7%)

0.765

 18.5–24.9

3790 (28.9%)

684 (25.6%)

3106 (29.8%)

< 0.001

 25–29.9

6044 (46.1%)

1213 (45.4%)

4831 (46.3%)

0.426

 ≥ 30

3183 (24.3%)

756 (28.3%)

2427 (23.3%)

< 0.001

Dyslipidemia

7609 (57.9%)

1664 (62.0%)

5945 (56.8%)

< 0.001

Hypertension

7050 (53.6%)

1460 (54.4%)

5590 (53.4%)

0.347

Diabetes mellitus

5034 (38.3%)

987 (36.8%)

4047 (38.7%)

0.073

COPD

317 (2.4%)

52 (2.0%)

265 (2.6%)

0.079

Renal failure

268 (2.0%)

45 (1.7%)

223 (2.1%)

0.134

Tobacco smoking

   

0.296

 Previous smoking

2464 (18.8%)

505 (18.9%)

1959 (18.8%)

 

 Current smoking

2522 (19.2%)

542 (20.2%)

1980 (19.0%)

 

Opium consumption

1848 (14.3%)

382 (14.5%)

1466 (14.3%)

0.824

Previous PCI

977 (7.4%)

235 (8.8%)

742 (7.1%)

0.003

Previous MI

5240 (39.8%)

1090 (40.6%)

4150 (39.6%)

0.354

LVEF (%)

46.86 ± 9.61

47.60 ± 9.56

46.67 ± 9.61

< 0.001

Left main coronary disease

1022 (7.8%)

188 (7.0%)

834 (8.0%)

0.098

Off-pump surgery

717 (5.4%)

130 (4.8%)

587 (5.6%)

0.121

Graft number

3 (3–4)

3 (3–4)

3 (3–4)

0.395

  1. Data are represented as mean ± standard deviation, median (interquartile range), or numbers (%); P-values < 0.05 are shown in bold font
  2. BMI, body mass index; COPD, chronic obstructive pulmonary disease; FHpCVD, family history of premature cardiovascular disease; LVEF, left ventricular ejection fraction; MI, myocardial infarction; PCI, percutaneous coronary intervention